The experimental model of multiple myeloma showed that anti-Dkk-1 antibody treatment reversed the inhibitory effect of Dkk-1 on osteoblasts’ differentiation and bone formation, thus reducing bone loss (Fulciniti et al., 2009). This evidence concerns the gene DKK1 and plasma cell myeloma.